Shares of Catalyst Pharmaceuticals dropped 4.19% to $3.43 at 10:40 EST on Monday, after four consecutive sessions in a row of losses. The Nasdaq Stock Market is sliding 1.67% to $12,542.00, following yesterday's downward trend, This seems, at the moment, an all-around negative trend trading session today.
Catalyst Pharmaceuticals's last close was $3.58, 53.94% under its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the current quarter and 4.6% for the next. The company's growth estimates for the present quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals's stock is valued at $3.43 at 10:40 EST, way below its 52-week high of $5.28 and way higher than its 52-week low of $2.55.